Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16678648 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: ADHD
Intervention: Drug: Mixed salts of a single-entity amphetamine (ADDERALL XR)

Indicates status has not been verified in more than two years